Addressing an Unmet Need in EGFR mNSCLC

Insights from ELCC 2024
L

ELCC 2024 Insights: "Small Numbers, Big Impact - The Importance of Testing for Rare Mutations in mNSCLC"

By Insights from ELCC 2024 FEATURING Luka Brcic
By Insights from ELCC 2024 FEATURING Luka Brcic
248 views
April 11, 2024
0 Comments
Login to view comments. Click here to Login
10:18
Fawzi Abu Rous

Current Recommendations on Managing Dermatologic Adverse Reactions A…

09:09
Filippo de Marinis

PAPILLON Trial Results: Amivantamab + Chemo vs. Chemo as 1L Treatmen…

13:49
Giri Raval

The Importance of Staying on Therapy for EGFR exon 20 NSCLC

06:41
Insights from ELCC 2024

ELCC 2024 Insights: "The Frequency of Occurrence of EGFR PACC M…

Feat. X. Le
08:30
Insights from 2023 ESMO Annual Meeting

PAPILLON Study - Amivantamab + Chemo vs. Chemo as 1L Treatment in EG…

Feat. N. Girard
17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
26:21
Memorial Sloan Kettering Cancer Center

NSCLC & Targeted Therapy: A Brief Overview and Update in the Met…

Feat. M. Hwang